A major breakthrough in cancer study is arising with the use of mini-antibodies to reactivate dysfunctional p53. This crucial cancer inhibitor protein is frequently disabled in various forms of malignancies, resulting https://bookmarksusa.com/story22026566/mini-antibodies-reactivate-the-p53-protein-new-new-hope-for-malignant-therapy